Improving Patient Outcomes: AI-Based Phenotyping for Diagnosis, Treatment, and Clinical Trials

Watch Now

Sponsored by:

OM1
Date:
June 7, 2023
Time (PT):
2:00 PM
Duration (min):
60

Watch a panel of OM1's clinical experts in cardiometabolic disease, immunology, and mental health as they explore how Artificial Intelligence (AI) can find phenotypic patterns and unlock insights hidden in real-world data.

Extracting as much information as possible from real-world datasets is essential for understanding the complete patient journey. Subtle patterns in structured and unstructured data can provide insight into disease diagnosis, progression, treatment efficacy, and overall outcomes for subcohorts and individuals. Through digital phenotyping, AI can isolate these patterns to help us better address challenges in underdiagnosis or misdiagnosis, risk and safety, gaps in care, and opportunities for new treatment.

This webinar dives into how PhenOMTM, OM1's AI-powered digital phenotyping platform, and real-world data can enrich and inform:

  • Subtype phenotyping
  • Enhanced diagnostic screening
  • Risk and treatment differences
  • Clinical trial enrollment

Presenters

Gary Curhan

OM1 (Research)
Chief Medical Officer

Dr. Gary Curhan is Chief Medical Officer at OM1, a practicing nephrologist in Boston and has published widely on the epidemiology of many medical conditions including cardiovascular disease, hypertension, kidney stones, gout, and others. Dr. Curhan is a graduate of Harvard Medical School and Harvard School of Public Health.

Read More

Carl Marci

OM1 (Mental Health and Neuroscience)
Chief Psychiatrist and Managing Director

Dr. Carl Marci is the Chief Psychiatrist and Managing Director of Mental Health and Neuroscience at OM1.

Read More

Stefan Weiss

OM1
Managing Director of Dermatology

Dr. Stefan Weiss is the Managing Director of Dermatology at OM1. He is a board certified dermatologist, served on several national medical advisory committees and has published widely on psoriasis and atopic dermatitis. Dr. Weiss is a graduate of Yale Univ., and received his MD and MHSc in Clinical Research from the Duke Univ. School of Medicine.

Read More

Joseph Zabinski

OM1 (Data Solutions)
Managing Director of AI & Personalized Medicine

Dr. Joseph Zabinski is Managing Director of AI & Personalized Medicine at OM1. He specializes in applications of advanced analytics to real-world data in healthcare and life science contexts. He holds a master’s degree in engineering management from Dartmouth College, and a doctorate in health analytics from the School of Public Health at UNC.

Read More

Sponsor

OM1

With specialization in chronic diseases, OM1 is a leading real-world data, outcomes and technology company leveraging big clinical data and AI to better understand, compare, and predict patient outcomes.

Content Partners

HealthEconomics.com

HealthEconomics.com is the world’s largest Connected Community™ for Value, Evidence and Access in the life sciences industry.

HealthEconomics.com provides a single global link to the health economic and outcomes research (HEOR), real-world evidence (RWE), and Market Access (MA) stakeholder communities. Since 1993, we have provided unparalleled access to drive business, improve knowledge, and connect researchers and payer decision-makers world-wide.

Our 27,000 engaged readers rely on HealthEconomics.com as the most reliable, credible and curated digital hub for the latest news, insights, educational opportunities, and industry benchmarks in HEOR, RWE and MA. Our advertisers, numbering more than 500 with a 91% retention rate, depend upon HealthEconomics.com for best-in-class global brand awareness and business development solutions. Our aim is to connect people with expert-driven content and resources — all in one place — with the corporate mission to advance communication about healthcare value.

Related Content

Related Content